Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma

Int J Dermatol. 2017 Apr;56(4):e75-e77. doi: 10.1111/ijd.13513. Epub 2017 Jan 19.

Authors

Abraham M Korman^{1

2}, Kelly H Tyler¹, Benjamin H Kaffenberger¹

Affiliations

¹ Division of Dermatology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
² Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

PMID: 28102540
DOI: 10.1111/ijd.13513

No abstract available

Publication types

Letter

MeSH terms

Adult
Antineoplastic Agents, Immunological / adverse effects*
Bone Neoplasms / drug therapy*
Bone Neoplasms / radiotherapy
Bone Neoplasms / secondary
Humans
Lymphatic Metastasis
Male
Melanoma / drug therapy*
Melanoma / secondary
Nivolumab / adverse effects*
Radiodermatitis / chemically induced*
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology

Substances

Antineoplastic Agents, Immunological
Nivolumab